A single treatment with microcapsules containing a CXCR4 antagonist suppresses pulmonary metastasis of murine melanoma
- 10 June 2004
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 320 (1), 226-232
- https://doi.org/10.1016/j.bbrc.2004.05.155
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4FEBS Letters, 2002
- Expression of Functional Chemokine Receptors CXCR3 and CXCR4 on Human Melanoma CellsJournal of Biological Chemistry, 2001
- A Possible Role for CXCR4 and Its Ligand, the CXC Chemokine Stromal Cell-Derived Factor-1, in the Development of Bone Marrow Metastases in NeuroblastomaThe Journal of Immunology, 2001
- Involvement of chemokine receptors in breast cancer metastasisNature, 2001
- Conformational Changes in Cell Surface HIV-1 Envelope Glycoproteins Are Triggered by Cooperation between Cell Surface CD4 and Co-receptorsJournal of Biological Chemistry, 1998
- CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5Nature, 1996
- CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5Nature, 1996
- The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1Nature, 1996
- The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entryNature, 1996
- The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirusNature, 1984